{"id":"f34b5ebe-ce32-4ab1-98a3-043541589950","kind":"institutions","code":"UB-I10874","name":"4BIO Capital","nameBasis":"original-brand","summary":"4BIO Capital is a venture capital investor with 1 recorded investment.","description":"","country":null,"category":null,"originalName":"4BIO Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T23:34:17.023Z","englishUpdatedAt":"2026-10-16T01:39:56.108Z","reviewedAt":"2026-10-16T01:39:56.108Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"d86fb397c2e1572aa118add5c85ffe71d4fa9f5e16c59a770d62a81d8371e7d3","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"8cd069b7-9229-4d49-bb52-f1731fbca7ad","kind":"news","code":"8cd069b7-9229-4d49-bb52-f1731fbca7ad","name":"Targeted RNA drug company Undecimal Bio raises EUR 16 million in seed funding","nameBasis":"translated-title","summary":"Targeted RNA drug company Undecimal Bio completed EUR 16 million in seed funding from 4BIO Capital, IQ Capital and others.","description":"","country":null,"category":null,"originalName":"靶向RNA药物公司 Undecimal Bio 完成1600万欧元种子轮融资","eventDate":"2026-10-14T00:00:00.000Z","website":"https://aipressroom.com/undecimal-bio-16m-rna-delivery/","sourceUpdatedAt":"2026-10-15T23:34:18.417Z","englishUpdatedAt":"2026-10-16T01:41:13.662Z","reviewedAt":"2026-10-16T01:41:13.662Z","snapshotAt":"2026-10-16T01:38:14.029Z","sourceHash":"022d2e2c054552e7da9fa65bf9d19c3f49d63cb731b3a04aa12bc2f5e9bc392c","companyId":"37fbbcaa-21e8-41ec-a8fe-f63d3b59994e","foundedYear":null,"logoUrl":null,"path":"/news/8cd069b7-9229-4d49-bb52-f1731fbca7ad"}],"path":"/institutions/4bio-capital","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":null},"definition":"4BIO Capital is a venture capital investor with 1 recorded investment.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/institutions/4bio-capital"}